Transition Therapeutics News
Most Popular Transition Therapeutics Story
Transition, Lilly kill diabetes program after trial failure
Transition Therapeutics' diabetes drug, which is partnered with Eli Lilly, has run straight off the cliff. CEO Dr. Tony Cruz announced this morning that the drug--one of two clinical-stage Read more...
Latest Headlines
- September 17, 2010
- August 10, 2010
- December 15, 2009
- August 18, 2008
- March 17, 2008
- March 14, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
